Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria

Anne Catrin Uhlemann*, Nicole A. Szlezák, Reinhard Vonthein, Jürgen Tomiuk, Stefanie A. Emmer, Bertrand Lell, Peter G. Kremsner, Jürgen F.J. Kun

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Reactive oxygen intermediates (ROIs) play a major role in the nonspecific innate immune response to invading microorganisms, such as Plasmodium falciparum. In a search for genetic markers that determine differences in production of ROI, we detected a highly polymorphic region of dinucleotide TA repeats ∼550 bp upstream of the NADPH oxidase gp91phox subunit promoter. We genotyped 183 matched Gabonese children with severe or mild malaria. Repeat lengths TA11 and TA16 differed significantly in frequency between mild and severe infection, which suggests protection against severe malaria. Both repeat lengths showed lower levels of NADPH oxidase and promoter activities, which can be explained by a cyclic trend in TA repeat length with a period of ∼5, which indicates the necessity of correct DNA phasing between 2 possible control regions in the promoter. We provide a molecular model of how DNA phasing generated by TA dinucleotide polymorphisms may influence the expression level and protect against severe malaria.

OriginalspracheEnglisch
ZeitschriftJournal of Infectious Diseases
Jahrgang189
Ausgabenummer12
Seiten (von - bis)2227-2234
Seitenumfang8
ISSN0022-1899
DOIs
PublikationsstatusVeröffentlicht - 15.06.2004

Fördermittel

Received 28 August 2003; accepted 20 December 2003; electronically published 25 May 2004. Financial support: Bundesministerium für Bildung und Forschung (grant 01GS0114 to J.F.J.K., as a member of the National Genome Research Network). a Present affiliation: Department of Infectious Diseases, St. George’s Hospital Medical School, London, United Kingdom. Reprints or correspondence: Anne-Catrin Uhlemann, St. George’s Hospital Medical School, Cranmer Terrace, SW17 ORE, London, UK (a.uhlemann@sghms .ac.uk).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren